UK Markets close in 2 hrs 24 mins
  • FTSE 100

    +20.72 (+0.27%)
  • FTSE 250

    -81.95 (-0.44%)
  • AIM

    -2.16 (-0.27%)

    +0.0000 (+0.00%)

    +0.0005 (+0.0403%)

    +286.99 (+1.25%)
  • CMC Crypto 200

    +1.67 (+0.27%)
  • S&P 500

    -1.31 (-0.03%)
  • DOW

    -12.18 (-0.04%)

    -0.03 (-0.04%)

    +3.00 (+0.15%)
  • NIKKEI 225

    +520.94 (+1.93%)

    +332.67 (+1.73%)
  • DAX

    +76.17 (+0.50%)
  • CAC 40

    +28.59 (+0.40%)

Regenerative Medicine Market Report 2023-2033


Forecasts by Product (Cell Therapy (Autologous, Allogenic), Tissue Engineering (Scaffold, Hydrogels), Gene Therapy, Others), by Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis.

New York, March 16, 2023 (GLOBE NEWSWIRE) -- announces the release of the report "Regenerative Medicine Market Report 2023-2033" -

The Regenerative Medicine Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing number of Joint Ventures to fuel market growth

The demand for breakthrough techniques in tissue engineering, cell therapy, and stem cell use is increasing due to the rising prevalence of chronic diseases and clinical trials. Continuous joint ventures, mergers, acquisitions, and other strategic activity by various companies is helping the regenerative medicine market thrive. For instance, in October 2022, Dr. Vanessa Rodriguez Pares and Meso Numismatics, Inc. (MSSV), a biotech and numismatics-focused technology company, partnered with the new STEM LIFE clinic facility. This collaboration aims to promote regenerative medicine’s high standards. Similar to this, Astellas Pharma Inc. and Pantherna Therapeutics GmbH entered into a technology evaluation agreement in October 2022 to carry out research to create mRNA-based regenerative medicine programmes employing direct reprogramming (trans-differentiation). Additionally, in October 2020, the world’s largest pharmaceutical corporation Bayer bought Asklepios BioPharmaceutical, a gene therapy business with operations in San Sebastián, Spain, Edinburgh, and Paris, in a deal valued at up to US$ 4 billion. Such actions significantly influence the market for regenerative medicine’s growth pace.

Product Recalls may hamper the market growth

Regenerative medicine is a speedily evolving field and involves the use of wide array of techniques to repair or replace damaged tissues and organs. With the increasing popularity and use of these products, there have been instances of product recalls in the regenerative medicine market. The growth of the regenerative medicine market can be impeded owing to the increasing number of product recalls. Biotech companies continue to face difficulties such as risk of product recalls and marketing their genetic medicine in the market. For instance, Bluebird Bio, a US-based gene therapy company, withdrew its gene therapy for a rare blood disorder from the German market in April 2021 after failing to reach an agreement on the treatment’s cost with German health authorities. This recall impacted the company’s sales and brand image. Similarly, small-scale companies are severely affected as they fail to recover from losses due to product recalls because they operate without robust cash flow and brand recognition.

What Questions Should You Ask before Buying a Market Research Report?

• How is the Regenerative Medicine Market evolving?

• What is driving and restraining the Regenerative Medicine Market?

• How will each Regenerative Medicine submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?

• How will the market shares for each Regenerative Medicine submarket develop from 2023 to 2033?

• What will be the main driver for the overall market from 2023 to 2033?

• Will leading Regenerative Medicine Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?

• Who are the leading players and what are their prospects over the forecast period?

• What are the Regenerative Medicine development projects for these leading companies?

• How will the industry evolve during the period between 2023 and 2033? What are the implications of Regenerative Medicine development projects taking place now and over the next 10 years?

• Is there a greater need for product commercialisation to further scale the Regenerative Medicine Market?

• Where is the Regenerative Medicine Market heading and how can you ensure you are at the forefront of the market?

• What are the best investment options for new product and service lines?

• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Regenerative Medicine Market today, and over the next 10 years:

• Our 232-page report provides 101 tables and 108 charts/graphs exclusively to you.

• The report highlights key lucrative areas in the industry so you can target them – NOW.

• It contains in-depth analysis of global, regional and national sales and growth.

• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Regenerative Medicine Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.

• You will find original analyses, with business outlooks and developments.

• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of regenerative medicines and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

By Product

• Stem Cell Therapy

- Autologous

- Allogenic

• Tissue Engineering

- Scaffold

- Hydrogels

• Gene Therapy

• Others

By Application

• Regenerative Medicine

- Oncology

- Dermatology

- Musculoskeletal

- Neurology

- Cardiovascular

- Wound Healing

- Ophthalmology

- Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

• U.S.

• Canada


• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia Pacific

Latin America

• Brazil

• Mexico

• Rest of Latin America Latin America



• South Africa

• Rest of MEA

The report also includes profiles and for some of the leading companies in the Regenerative Medicine Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

• Amgen

• Anterogen

• Avita Medical Inc.

• Bio Solutions. Co. Ltd

• Bluebird Bio Inc.

• Bristol Myers Squibb

• Gilead Sciences, Inc.

• Integra Life Sciences

• Misoblast Ltd

• Novartis AG

• Organogenesis Inc.

• Sarepta Therapeutics,Inc

• Sibino GeneTech Co. Ltd

• Smith and Nephew plc

• Terumo BCT

Overall world revenue for Regenerative Medicine Market, 2023 to 2033 in terms of value the market will surpass US$ 59.15 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Regenerative Medicine Market, 2023 to 2033 report help you?

In summary, our 232-page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Regenerative Medicine Market, 2023 to 2033 Market, with forecasts for Type of Product and Application at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Regenerative Medicine Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Regenerative Medicine Market, 2023 to 2033.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001